Moberg Pharma AB (Formerly known as Moberg Derma) Extends Distribution Agreement With Menarini Group For Emtrix To Russia

Regulatory News:

Moberg Pharma AB (OMX: MOB) today announced that Berlin-Chemie AG, a member of the Menarini Group – a top 40 global pharmaceutical company – has been granted the exclusive rights to market and sell Emtrix® in Russia and Ukraine.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC